CQ38. Does Combined Modality Therapy for Anaplastic Carcinoma Improve Prognosis?
Most anaplastic carcinomas are locally progressive and show distant metastasis at diagnosis. To control local and distant lesions and improve the survival rates and QOL, combined modality therapy is performed. In the past, responders obtained prolonged survival rates, although there are no reports for effective regimens. However, therapy evaluation should be performed frequently and a change of therapeutic strategy is necessary when the current treatment is judged ineffective.
KeywordsDistant Metastasis External Beam Radiotherapy Effective Regimen Weekly Paclitaxel Anaplastic Carcinoma
- 10.Chemotherapy Committee, The Japanese Society of Thyroid Surgery (1995) Intensive chemotherapy for anaplastic thyroid carcinoma: combination of cisplatin, doxorubicin, etoposide and peplomycin with granulocyte colony-stimulating factor support. Jpn J Clin Oncol 25:203–207 (RS)Google Scholar
- 15.Yamashita T, Shimaoka K, Ito K et al (1992) (Text in Japanese) Naibunpitsugeka 9:213–218 (RS)Google Scholar